NEU 2.17% $20.25 neuren pharmaceuticals limited

Acadia might have paid a premium for the ROW rights so they can...

  1. 724 Posts.
    lightbulb Created with Sketch. 167
    Acadia might have paid a premium for the ROW rights so they can get access to the 2591 data to decide what the next step is. Prior to this deal, neuren could block Acadia from seeing a lot of the 2591 science as it would be commercial in confidence
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.25
Change
0.430(2.17%)
Mkt cap ! $2.585B
Open High Low Value Volume
$19.89 $20.39 $19.77 $5.715M 283.6K

Buyers (Bids)

No. Vol. Price($)
1 355 $20.22
 

Sellers (Offers)

Price($) Vol. No.
$20.29 302 1
View Market Depth
Last trade - 16.10pm 07/05/2024 (20 minute delay) ?
Last
$20.22
  Change
0.430 ( 2.40 %)
Open High Low Volume
$19.86 $20.40 $19.77 85257
Last updated 15.59pm 07/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.